Axena Health’s Leva® Pelvic Health System Now Available to Female Veterans Through Federal Healthcare Providers

The women’s pelvic health company will now provide greater treatment access for the more than 2 million female veterans in the U.S.

Axena Health, Inc. (Axena Health), a women’s health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced female veterans now have access to the Leva Pelvic Health System through their federal healthcare providers, including the Veterans Health Administration (VHA), VA Community Care Network (CCN) and Military Health System (MHS).

“We’re proud that providers at federal healthcare facilities can now prescribe the Leva Pelvic Health System as an effective, first-line treatment for urinary incontinence,” said Randy Pritchard, CEO of Axena Health. “Leva enables supervised, at-home pelvic floor muscle training, giving women a convenient, and clinically proven option to manage urinary incontinence. Our modern approach is reducing barriers to care and helping more women – now including those who have served our country – access the treatment they deserve.”

Up to 20 percent of female veterans experience urinary incontinence (UI), a condition that often goes untreated due to stigma and barriers to access. Many veterans face heightened risks for UI due to factors such as extended periods without urination and a history of lifting heavy protective gear. These unique challenges, combined with common risk factors like pregnancy, childbirth, and menopause, increase UI risk among female veterans.

The Leva System is designed to provide women with a convenient, non-invasive option for treating UI through a modern approach to supervised pelvic floor muscle training. The physician-prescribed program uniquely combines the FDA-cleared Leva device and smartphone app to provide at-home guided treatment, personalized coaching, educational resources, and progress tracking.

Leva is now available on the Department of Veterans Affairs’ Federal Supply Schedule (FSS), GSA Advantage, and the Department of Defense’s Distribution and Pricing Agreement (DAPA) through a partnership with Lovell^® Government Services, a Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor.

“We’re proud to partner with Axena Health to advance technology that improves women’s health. Enhancing care for our female veterans is incredibly important to our company,” said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services.

For more information about the Leva Pelvic Health System, visit levacares.com.

About Axena Health

Axena Health, Inc. is dedicated to improving the lives of women with pelvic floor disorders. Axena Health’s flagship product, the Leva® Pelvic Health System, offers a novel, effective, first-line treatment for urinary incontinence (UI) and chronic fecal incontinence (FI), underreported conditions affecting over 78 million and 12 million women in the U.S. alone. Axena Health's technology enables a modern approach to supervised pelvic floor muscle training via precise visualization of movement in real time, while monitoring usage and progress. For more information, please visit www.axenahealth.com or www.levacares.com and follow Axena Health on LinkedIn.

About the Leva® Pelvic Health System

The Leva® Pelvic Health System offers an innovative, non-invasive, medication-free way for women to treat urinary incontinence (UI) and chronic fecal incontinence (FI) — at home in just five minutes a day. Combining a small FDA-cleared vaginal motion sensor with integrated software, the Leva System offers precise, real-time visualization of pelvic movement, progress tracking and active physician involvement, all of which support improved treatment outcomes. The Leva System is available by prescription only, enabling physician engagement in each patient’s success while also offering scalable first-line treatment of UI and chronic FI. The Leva System has multiple clinical trials and published data from globally recognized medical centers supporting its efficacy in treating UI, including two studies in Obstetrics and Gynecology (The Green Journal), the official publication of the American College of Obstetricians and Gynecologists (ACOG).

Important Indication and Other Information for the Leva® Pelvic Health System

The Leva® Pelvic Health System is intended for (1) strengthening of pelvic floor muscles, (2) rehabilitation and training of weak pelvic floor muscles for the treatment of stress, mixed, and mild to moderate urgency urinary incontinence (including overactive bladder) in women and (3) rehabilitation and training of weak pelvic floor muscles for the first-line treatment of chronic fecal incontinence (>3-month uncontrolled passage of feces) in women. Treatment with the Leva System is by prescription and is not for everyone. Please talk to your prescriber to see if Leva System is right for you. Your prescriber should discuss all potential benefits and risks with you. Do not use Leva System while pregnant, or if you think you may be pregnant, unless authorized by your doctor. For a complete summary of the risks and instructions for the Leva System, see its Instructions for Use available at www.levacares.com.

About Lovell Government Services

Lovell Government Services has been a trusted SDVOSB vendor since 2013 with a proven track record of successfully introducing suppliers to the government market. Lovell is a three-time Inc. 5000 honoree and leader in the federal space. They partner with medical and pharmaceutical companies looking to better serve Veteran and military patient populations, increase their federal revenue stream, and win government contracts.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250520401137/en/

We’re proud that providers at federal healthcare facilities can now prescribe the Leva Pelvic Health System as an effective, first-line treatment for urinary incontinence.